R&D Sponsored Advancing RSV and hMPV research through human challenge tria... Human challenge trials offer a complementary approach, and hVIVO has been at the forefront of this field for decades.
Patients The ins and outs of HEOR – A lever for global health Web editor Nicole Raleigh speaks with Rob Abbott, CEO and executive director of ISPOR, about the ins and outs and trends of HEOR.
Patients Op-ed: Pharma must show courage, leadership on public health Pharma companies can't claim to care about global patient wellbeing unless they stand up to Trump's public health cuts.
Digital Retaining the human element in healthcare services whilst em... In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Gavin Anderson, a man of many hats all orbiting around technology and business.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.